Susquehanna International Group’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-125,600
| Closed | -$580K | – | 11223 |
|
|
2019
Q1 | $580K | Buy |
125,600
+44,700
| +55% | +$212K | ﹤0.01% | 6005 |
|
|
2018
Q4 | $283K | Sell |
80,900
-128,300
| -61% | -$892K | ﹤0.01% | 7118 |
|
|
2018
Q3 | $2.11M | Sell |
209,200
-253,700
| -55% | -$2.02M | ﹤0.01% | 3894 |
|
|
2018
Q2 | $3.35M | Buy |
462,900
+107,400
| +30% | +$749K | ﹤0.01% | 3243 |
|
|
2018
Q1 | $2.15M | Buy |
355,500
+95,400
| +37% | +$788K | ﹤0.01% | 3784 |
|
|
2017
Q4 | $2.5M | Sell |
260,100
-32,700
| -11% | -$214K | ﹤0.01% | 3524 |
|
|
2017
Q3 | $2.6M | Sell |
292,800
-12,700
| -4% | -$131K | ﹤0.01% | 3453 |
|
|
2017
Q2 | $3.87M | Sell |
305,500
-7,700
| -2% | -$91.1K | ﹤0.01% | 2755 |
|
|
2017
Q1 | $3.29M | Sell |
313,200
-55,000
| -15% | -$586K | ﹤0.01% | 2897 |
|
|
2016
Q4 | $3.39M | Buy |
368,200
+29,600
| +9% | +$334K | ﹤0.01% | 3028 |
|
|
2016
Q3 | $3.99M | Buy |
338,600
+35,500
| +12% | +$540K | ﹤0.01% | 2515 |
|
|
2016
Q2 | $3.92M | Sell |
303,100
-77,500
| -20% | -$1.13M | ﹤0.01% | 2536 |
|
|
2016
Q1 | $6.09M | Buy |
380,600
+84,200
| +28% | +$1.6M | ﹤0.01% | 2060 |
|
|
2015
Q4 | $8.49M | Buy |
296,400
+42,300
| +17% | +$1.17M | ﹤0.01% | 1921 |
|
|
2015
Q3 | $7.23M | Sell |
254,100
-159,400
| -39% | -$5.87M | ﹤0.01% | 2191 |
|
|
2015
Q2 | $14.9M | Buy |
413,500
+301,500
| +269% | +$9.39M | 0.01% | 1592 |
|
|
2015
Q1 | $3.25M | Buy |
112,000
+18,800
| +20% | +$497K | ﹤0.01% | 3404 |
|
|
2014
Q4 | $1.97M | Sell |
93,200
-261,200
| -74% | -$5.16M | ﹤0.01% | 4497 |
|
|
2014
Q3 | $6.87M | Buy |
354,400
+94,500
| +36% | +$1.48M | ﹤0.01% | 2573 |
|
|
2014
Q2 | $4.06M | Buy |
259,900
+157,000
| +153% | +$2.54M | ﹤0.01% | 3416 |
|
|
2014
Q1 | $2.13M | Buy |
102,900
+51,600
| +101% | +$1.02M | ﹤0.01% | 4240 |
|
|
2013
Q4 | $662K | Buy |
+51,300
| New | +$712K | ﹤0.01% | 6244 |
|
Other funds holding INSY
WS
Susquehanna International Group's INSY Position: Q2 2019 in Review
Susquehanna International Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 21,561 shares — an estimated $100K sold.
Susquehanna International Group first reported a position in INSY in Q2 2014 and held it in 13 quarters. The position peaked at $1.87M in Q3 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Susquehanna International Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Susquehanna International Group sold 21,561 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $100K.
- Susquehanna International Group first reported a position in Insys Therapeutics, Inc. in Q2 2014 and held it in 13 quarters.
- Susquehanna International Group's Insys Therapeutics, Inc. position peaked at $1.87M in Q3 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.